MedTrace Logo

Evaluation of the Effectiveness of a Very Brief Smoking Cessation Intervention in Family Health Centers

NCT07030387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2025-06-22

No results posted yet for this study

Summary

In Turkey, the prevalence of tobacco use among individuals was 31.4% in 2019. The WHO recommends brief and very brief interventions to increase tobacco cessation rates and medical support. In developing countries, these brief interventions are being integrated into primary care. The aim of this study is to evaluate the effectiveness of very brief interventions at different family health centers in Aydın province.

A pragmatic randomized controlled trial was conducted with 170 patients in intervention group and 161 in control group across 14 family health centers in Aydın province from June 2023 to December 2023. Physicians that recurited for intervention received one hour of online training before applying very brief smoking cessation interventions to their patients. Data collection included a baseline assessment of sociodemographic characteristics, smoking status, and medical history. At the three-month follow-up, participants' cessation status and motivations were assessed via phone call interviews. Intention to Treat approach was utilized. Secondary outcomes included the objective and subjective frequency of smoking, as well as treatment and support received.

Conditions

  • Smoking Cessation; Tobacco Dependence

Interventions

BEHAVIORAL

Smoking cessation counselling group

3A-OR very brief intervention for smoking cessation

BEHAVIORAL

Control group patients were those who had not received the 3A-OR intervention

Control Group (Patients of the other family physicians in the same family health centers)

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Okay BAŞAK, MD, PhD · Aydın Adnan Menderes University, School of Medicine, Department of Family Medicine

  • Melda DİBEK, MD, PhD · Aydın Adnan Menderes University, School of Medicine, Department of Family Medicine

  • Yiğit YAĞCI, MD · Aydın Adnan Menderes University, School of Medicine, Department of Family Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-12-31
Completion
2024-03-31

Countries

  • Turkey (Türkiye)

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07030387 on ClinicalTrials.gov